Tag Archives: EU

Europe Wrestles with Outdated Clinical Research Rules

By Guest Blogger | Published: August 31, 2011
By Reflector, Brussels correspondent. Man can live as a free being only when he is free to develop his innate abilities, maintained Baruch Spinoza, that quintessential European, back in the 17th century. He might have been talking about the aspirations in the European pharmaceutical sector, which is currently struggling to articulate a clear plan for escaping [...]
Posted in Europe, Global, Guest Blog, R&D, Regulatory | Also tagged , , | 1 Comment

FDA Finding Fuels Indian Crackdown on Sub-standard Drugs

By Guest Blogger | Published: July 27, 2011
By Mangesh Sai, Asia Correspondent. A routine monthly inspection carried out by the Food and Drugs Administration (FDA) authorities in the state of Maharashtra, India, last month noted an increase in the number of sub-standard drug samples raising apprehensions about the availability of safe and genuine drugs in the state. Officials pointed out that 26 drug samples [...]
Posted in Anti-counterfeiting, Global, Guest Blog, IP, Safety | Also tagged , , , | Leave a comment

Europe: Into the HTA Fray

By Guest Blogger | Published: July 27, 2011
Reflector finds some surprising common ground in what should be two very different HTA reports. Just like with buses, you wait for ages for an international review of health technology assessment to come along, then two turn up at once.
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment

Seeing Through the EU Transparency Directive

By Guest Blogger | Published: May 4, 2011
Reflector outlines why the EU’s so-called “transparency directive” has not set the industry on fire. For such a big subject, it is receiving little public attention. No matter how much pharma executives eulogise the heady prospects for personalised medicine or the protean potential of pharmacogenomics, everything all comes down, at the end of the day, to money. [...]
Posted in Europe, Global, Guest Blog, Regulatory, pricing | Also tagged , , | Leave a comment

Europe Unites Over Counterfeiting

By Guest Blogger | Published: February 28, 2011
Imitation may the sincerest form of flattery, but it isn’t always welcome. Particularly when the imitations are fakes through and through. That explains why Europe’s new rules to combat counterfeit medicines are winning such widespread applause, says Reflector. It isn’t customary for European Union legislation to win backing from all sides. Usually, there’s a large rump [...]
Posted in Europe, Global, Guest Blog, Supply Chain | Also tagged , | Leave a comment